1. Home
  2. WPP vs TMDX Comparison

WPP vs TMDX Comparison

Compare WPP & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WPP plc

WPP

WPP plc

HOLD

Current Price

$15.05

Market Cap

4.0B

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$113.45

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WPP
TMDX
Founded
1985
1998
Country
United Kingdom
United States
Employees
104000
N/A
Industry
Advertising
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
4.6B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
WPP
TMDX
Price
$15.05
$113.45
Analyst Decision
Hold
Buy
Analyst Count
2
9
Target Price
N/A
$154.00
AVG Volume (30 Days)
608.8K
880.3K
Earning Date
02-26-2026
05-07-2026
Dividend Yield
13.98%
N/A
EPS Growth
N/A
382.18
EPS
N/A
4.87
Revenue
N/A
$605,494,000.00
Revenue This Year
N/A
$24.12
Revenue Next Year
$2.48
$18.69
P/E Ratio
$38.96
$23.34
Revenue Growth
N/A
37.13
52 Week Low
$14.81
$62.42
52 Week High
$40.95
$156.00

Technical Indicators

Market Signals
Indicator
WPP
TMDX
Relative Strength Index (RSI) 30.73 33.27
Support Level N/A $106.27
Resistance Level $19.55 $131.86
Average True Range (ATR) 0.55 7.08
MACD -0.13 -2.50
Stochastic Oscillator 7.98 8.26

Price Performance

Historical Comparison
WPP
TMDX

About WPP WPP plc

Headquartered in the United Kingdom, WPP is the world's largest ad holding company based on annual revenue. Its services, which include traditional and digital advertising, public relations, and consulting, are provided worldwide, with over 70% of its revenue coming from more developed regions such as North America, the UK, and Western Europe. WPP is the largest media buying entity in the world.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: